Eden Research (LON:EDEN) Shares Down 3.3% – What’s Next?

Eden Research plc (LON:EDEN)’s stock price was down 3.3% on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). Approximately 450,985 shares traded hands during trading, a decline of 52% from the average daily volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26. The stock has a market capitalization of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The business has a 50-day moving average price of GBX 3.88 and a two-hundred day moving average price of GBX 3.95.

Insiders Place Their Bets

In other Eden Research news, insider Lykele van der Broek bought 256,000 shares of the business’s stock in a transaction on Thursday, February 6th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Also, insider Alexander John Abrey bought 540,540 shares of Eden Research stock in a transaction on Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.